APA (7th ed.) Citation

A, G., D, V., L, A., P, V., P, N., V, R., . . . G, G. (2022). Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. NPJ breast cancer, 8(1), 38. https://doi.org/10.1038/s41523-022-00409-x

Chicago Style (17th ed.) Citation

A, Gombos, et al. "Author Correction: FDG Positron Emission Tomography Imaging and CtDNA Detection as an Early Dynamic Biomarker of Everolimus Efficacy in Advanced Luminal Breast Cancer." NPJ Breast Cancer 8, no. 1 (2022): 38. https://doi.org/10.1038/s41523-022-00409-x.

MLA (9th ed.) Citation

A, Gombos, et al. "Author Correction: FDG Positron Emission Tomography Imaging and CtDNA Detection as an Early Dynamic Biomarker of Everolimus Efficacy in Advanced Luminal Breast Cancer." NPJ Breast Cancer, vol. 8, no. 1, 2022, p. 38, https://doi.org/10.1038/s41523-022-00409-x.